IBDEI1HG ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23989,1,3,0)
 ;;=3^Transsexualism
 ;;^UTILITY(U,$J,358.3,23989,1,4,0)
 ;;=4^F64.0
 ;;^UTILITY(U,$J,358.3,23989,2)
 ;;=^121404
 ;;^UTILITY(U,$J,358.3,23990,0)
 ;;=B35.1^^82^1041^59
 ;;^UTILITY(U,$J,358.3,23990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23990,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,23990,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,23990,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,23991,0)
 ;;=L03.90^^82^1041^3
 ;;^UTILITY(U,$J,358.3,23991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23991,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,23991,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,23991,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,23992,0)
 ;;=L03.91^^82^1041^7
 ;;^UTILITY(U,$J,358.3,23992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23992,1,3,0)
 ;;=3^Lymphangitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,23992,1,4,0)
 ;;=4^L03.91
 ;;^UTILITY(U,$J,358.3,23992,2)
 ;;=^5009068
 ;;^UTILITY(U,$J,358.3,23993,0)
 ;;=L25.9^^82^1041^4
 ;;^UTILITY(U,$J,358.3,23993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23993,1,3,0)
 ;;=3^Contact Dermatitis,Unspec Cause
 ;;^UTILITY(U,$J,358.3,23993,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,23993,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,23994,0)
 ;;=L40.0^^82^1041^54
 ;;^UTILITY(U,$J,358.3,23994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23994,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,23994,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,23994,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,23995,0)
 ;;=L40.2^^82^1041^1
 ;;^UTILITY(U,$J,358.3,23995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23995,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,23995,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,23995,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,23996,0)
 ;;=L40.3^^82^1041^57
 ;;^UTILITY(U,$J,358.3,23996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23996,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,23996,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,23996,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,23997,0)
 ;;=L40.4^^82^1041^5
 ;;^UTILITY(U,$J,358.3,23997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23997,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,23997,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,23997,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,23998,0)
 ;;=L40.8^^82^1041^55
 ;;^UTILITY(U,$J,358.3,23998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23998,1,3,0)
 ;;=3^Psoriasis,Other
 ;;^UTILITY(U,$J,358.3,23998,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,23998,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,23999,0)
 ;;=L40.9^^82^1041^56
 ;;^UTILITY(U,$J,358.3,23999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23999,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,23999,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,23999,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,24000,0)
 ;;=L57.0^^82^1041^2
 ;;^UTILITY(U,$J,358.3,24000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24000,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,24000,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,24000,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,24001,0)
 ;;=L97.911^^82^1041^33
 ;;^UTILITY(U,$J,358.3,24001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24001,1,3,0)
 ;;=3^Non-Prs Chr Ulc,RLL,Ltd to Brkdwn Skin
 ;;^UTILITY(U,$J,358.3,24001,1,4,0)
 ;;=4^L97.911
 ;;^UTILITY(U,$J,358.3,24001,2)
 ;;=^5133679
